GVR Report cover Atherectomy Devices Market Size, Share & Trends Report

Atherectomy Devices Market Size, Share & Trends Analysis Report By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-416-1
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Report Overview

The global atherectomy devices market size was valued at USD 890.3 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2023 to 2030. Owing to the rising prevalence of target diseases such as coronary artery disease (CAD) and peripheral artery disease (PAD). The prevalence of these diseases is increasing globally, due to factors such as the aging population, unhealthy lifestyles obesity. According to the National Center of Biotechnology Information, (NCBI), more than 230 million people worldwide suffer from peripheral artery disease (PAD), with high prevalence in the geriatric population. Additionally, there is an estimated increase in PAD prevalence of more than 17%. Furthermore, globally, in 2019, 113, million people lived with PAD and 10 million new cases occurred, resulting in 74,063 deaths. The growing demand for minimally invasive procedures and the increasing number of patients with cardiovascular disease is driving the growth of the market.

U.S. Atherectomy Devices Market size and growth rate, 2023 - 2030

The COVID-19 pandemic harmed the atherectomy devices market. The pandemic has decreased interest in the number of elective procedures, including atherectomy procedures. Hospitals and clinics were overwhelmed with patients with COVID-19, which has caused a decrease in the availability of resources for elective procedures. In addition, patients were reluctant to undergo elective procedures due to concerns about the risk of contracting COVID-19. The restrictions imposed by the government to slow down the spread of COVID-19 decreased the demand for atherectomy devices.

The demand for minimally invasive surgeries/procedures (MIS) is on the rise as these surgeries have a success rate of around 90%. These procedures result in fewer traumas to the patient and quicker recovery than invasive procedures. An additional reason for this shift is the possibility of the occurrence of infection with invasive surgeries. Atherectomy is a minimally invasive procedure, therefore, the rising demand for minimally invasive surgeries is expected to render a high-impact driver for the market during the forecast period.

Traditionally, open surgery has been used to address plaque buildup. which is invasive, hazardous, and takes a long time to recover from. However, atherectomy devices, have allowed doctors to undertake less intrusive treatments that enable speedier recovery times and decreased risk of complications. In addition, atherectomy devices have the potential to increase drug efficacy by evaluating the use of orbital atherectomy to treat CAD in patients who are not eligible for Coronary Artery Bypass (CAB) grafting and evaluating the use of rotational atherectomy to treat PAD in patients who are not eligible for Endovascular Therapy (EVT). The results of these clinical trials are expected to further demonstrate the potential of atherectomy devices and could lead to their wider adoption in the treatment of cardiovascular diseases.

Type Insights

Based on type, the market has been segmented into directional, rotational, orbital, and laser atherectomy devices. The directional atherectomy segment dominated the market with the largest revenue share of 35.9% in 2022 owing to its advantages such as availability in various sizes and the ability of plaque debulking as they can precisely target and remove plaque, without damaging the surrounding tissue and less likely to cause bleeding or damage to the artery.

In August 2021, Medtronic updated its old medical device HawkOne Directional Atherectomy System which was launched in 2015 to boost its presence in the global market. Food and Drug Administration (FDA) approved the device application update. Various clinical trials to prove the efficacy of the device also contribute to the high demand. Clinical trials such as DEFINITIVE LE, which evaluated the efficacy of the SilverHawk peripheral plaque excision system for the treatment of infrainguinal vessels and lower extremities, and EASE (Endovascular Atherectomy Safety and Effectiveness), have demonstrated a success rate exceeding 90%, thereby providing compelling evidence regarding the effectiveness of these specific medical devices.

The laser atherectomy segment is expected to grow at the fastest CAGR of 9.4% over the forecast period from 2023 to 2030 as these devices have become more sophisticated over the past few years, making them more effective and safer. This has led to increased adoption of laser atherectomy by physicians. The increasing prevalence of peripheral artery disease (PAD) is driving the segment as Laser atherectomy is a minimally invasive procedure that can be used to remove plaque and improve blood flow in the legs. In September 2020, AngioDynamics, Inc. which is a leading provider of PAD, minimally invasive medical devices for vascular access, and oncology; launched the Auryon Atherectomy System. It is an innovative and newly developed device for the treatment of different peripheral artery diseases, such as; In-Stent Restenosis (ISR), and Critical Limb Ischemia (CLI).

The rotational atherectomy devices segment held a significant revenue share in 2022 due to the increased prevalence of cardiovascular disease and improvement in the safety and effectiveness of treating a variety of cardiovascular conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. For example, they are increasingly being used to treat calcified lesions, which were previously difficult to treat with other methods. and also less expensive than other treatment options. In April 2022, Rotapro Rotational Atherectomy Device was launched to treat triple vessel disease which is an extreme] form of CAD. Medica (Kolkata) was the first hospital to use this technology to cure a 70-year-old man suffering from triple vessel disease.

The reimbursement scenario is also favorable for atherectomy devices, contributing to its growth. In November 2018, the Centers for Medicare and Medicaid Services released the 2019 reimbursement scenario. The reimbursement rates for the hospital outpatient payment system for atherectomy were decreased by 8%. Additionally, in August 2020, the Ministry of Solidarity and Health initiated to reimburse Rotapro and Rotalink Plus which are rotational atherectomy systems by Boston Scientific Corporation. The devices were listed in Title V of the List of Reimbursable Products and Services (LPPR List).

Regional Insights

North America dominated the market with the largest revenue share of 41.5% in 2022. Suitable reimbursement scenarios and a high number of FDA-approved devices are the key reasons for this dominance. For instance, in April 2019, Avinger, Inc. received 510(k) clearance from the FDA for Pantheris SV (Small Vessel) image-guided atherectomy system. A product line extension of its Lumivascular image-guided atherectomy platform is expected in the Pantheris market by 50% thereby increasing its share in the global market.

Global Atherectomy Devices Market share and size, 2022

Asia Pacific is expected to grow at the fastest CAGR of 9.5% over the forecasted period from 2023 to 2030. Factors like socioeconomic changes, unhealthy diets, smoking, consumption of alcohol, and an aging population have resulted in an increase in target diseases. Around 114 million people were affected by PAD in 2022 in the region. The prevalence of PAD increased with age, with 18.38% of men and 18.83% of women aged 85-89 years affected. Factors such as the increasing prevalence of PAD in the region, in addition to increasing product approvals, indicate the huge scope for market expansion in the region. For instance, in September 2022, Lepu Medical Technology Co. Ltd. received approval from the National Medical Products Administration (NMPA) to launch its peripheral cutting balloon to treat PAD in Beijing, China.

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach. For instance, in February 2023, Abbott announced the acquisition of Cardiovascular Systems, Inc. According to the agreement, Abbott was set to acquire Cardiovascular Systems, Inc. for a sum of approximately USD 890 million, equivalent to a payment of USD 20 per share. This acquisition is expected to enable the integration of Cardiovascular Systems, Inc.'s portfolio of medical devices into Abbott's existing range of products, which are dedicated to treating vascular diseases. Abbott's product lineup will encompass their existing guidewires, catheters, and plaque-disrupting devices employed in atherectomies, as well as a pipeline of minimally invasive technologies designed for the removal of blood clots, presently in the developmental stage.

Similarly, in December 2021, Koninklijke Philips N.V. announced the acquisition of Vesper Medical Inc., a U.S.-based medical technology company specializing in the development of minimally invasive peripheral vascular devices. Through this acquisition, Koninklijke Philips N.V. enhanced its existing portfolio of diagnostic and therapeutic devices by incorporating Vesper Medical Inc.'s cutting-edge venous stent portfolio, specifically designed for the treatment of deep venous disease. This strategic move enabled Koninklijke Philips N.V. to further expand its offerings in the field of vascular healthcare. The following are some of the major participants in the global atherectomy devices market:

  • Boston Scientific Corporation

  • Cardiovascular Systems, Inc.

  • Medtronic

  • Avinger

  • Koninklijke Philips N.V.

  • BD

  • Abbott

  • Cordis

  • Terumo Medical Corporation

Atherectomy Devices Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 955.7 million

Revenue forecast in 2030

USD 1,648.2 million

Growth rate

CAGR of 8.1% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

Report updated

September 2023

Quantitative units

Revenue in USD million and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait

Key companies profiled

Boston Scientific Corporation; Cardiovascular Systems, Inc.; Medtronic; Avinger; Koninklijke Philips N.V.; BD; Abbott; Cordis; Terumo Medical Corporation

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Atherectomy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global atherectomy devices market based on type, and region:

Global Atherectomy Devices Market Report Segmentation

  • Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Directional Atherectomy

    • Rotational Atherectomy

    • Orbital Atherectomy

    • Laser Atherectomy

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Atherectomy Devices Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Type
                        1.1.2. Regional scope
                        1.1.3. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Atherectomy Devices Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Atherectomy Devices Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                        3.3.2. Market Restraint Analysis
                    3.4. Atherectomy Devices Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic Landscape
Chapter 4. Atherectomy Devices: Type Estimates & Trend Analysis
                    4.1. Atherectomy Devices Market: Key Takeaways
                    4.2. Atherectomy Devices Market: Movement & Market Share Analysis, 2022 & 2030
                    4.3. Directional Atherectomy
                        4.3.1. Directional atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.4. Rotational Atherectomy
                        4.4.1. Rotational atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. Orbital Atherectomy
                        4.5.1. Orbital atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Laser Atherectomy
                        4.6.1. Laser atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Atherectomy Devices Market: Regional Estimates & Trend Analysis
                    5.1. Regional Outlook
                    5.2. Atherectomy Devices Market by Region: Key Takeaway
                    5.3. North America
                        5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.3.2. U.S.
                            5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.3.3. Canada
                            5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.4. Europe
                        5.4.1. UK
                            5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.2. Germany
                            5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.3. France
                            5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.4. Italy
                            5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.5. Spain
                            5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.6. Sweden
                            5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.7. Norway
                            5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.8. Denmark
                            5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.5. Asia Pacific
                        5.5.1. Japan
                            5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.2. China
                            5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.3. India
                            5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.4. Australia
                            5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.5. Thailand
                            5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.6. South Korea
                            5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.6. Latin America
                        5.6.1. Brazil
                            5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.6.2. Mexico
                            5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.6.3. Argentina
                            5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.7. MEA
                        5.7.1. Saudi Arabia
                            5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.2. South Africa
                            5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.3. UAE
                            5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.4. Kuwait
                            5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Market Participant Categorization
                        6.2.1. Boston Scientific Corporation
                            6.2.1.1. Company overview
                            6.2.1.2. Financial performance
                            6.2.1.3. Product benchmarking
                            6.2.1.4. Strategic initiatives
                        6.2.2. Cardiovascular Systems, Inc.
                            6.2.2.1. Company overview
                            6.2.2.2. Financial performance
                            6.2.2.3. Product benchmarking
                            6.2.2.4. Strategic initiatives
                        6.2.3. Medtronic
                            6.2.3.1. Company overview
                            6.2.3.2. Financial performance
                            6.2.3.3. Product benchmarking
                            6.2.3.4. Strategic initiatives
                        6.2.4. Avinger
                            6.2.4.1. Company overview
                            6.2.4.2. Financial performance
                            6.2.4.3. Product benchmarking
                            6.2.4.4. Strategic initiatives
                        6.2.5. Koninklijke Philips N.V.
                            6.2.5.1. Company overview
                            6.2.5.2. Financial performance
                            6.2.5.3. Product benchmarking
                            6.2.5.4. Strategic initiatives
                        6.2.6. BD
                            6.2.6.1. Company overview
                            6.2.6.2. Financial performance
                            6.2.6.3. Product benchmarking
                            6.2.6.4. Strategic initiatives
                        6.2.7. Abbott
                            6.2.7.1. Company overview
                            6.2.7.2. Financial performance
                            6.2.7.3. Product benchmarking
                            6.2.7.4. Strategic initiatives
                        6.2.8. Cordis
                            6.2.8.1. Company overview
                            6.2.8.2. Financial performance
                            6.2.8.3. Product benchmarking
                            6.2.8.4. Strategic initiatives
                        6.2.9. Terumo Medical Corporation
                            6.2.9.1. Company overview
                            6.2.9.2. Financial performance
                            6.2.9.3. Product benchmarking
                            6.2.9.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviations
Table 2 North America atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 3 North America atherectomy devices market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 5 Canada atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 6 Europe atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 7 Europe atherectomy devices market, by region, 2018 - 2030 (USD Million)
Table 8 Germany atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 9 UK atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 10 France atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 11 Italy atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 12 Spain atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 13 Sweden atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 14 Norway atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 15 Denmark atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 17 Asia Pacific atherectomy devices market, by region, 2018 - 2030 (USD Million)
Table 18 China atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 19 Japan atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 20 India atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 21 Australia atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 22 Thailand atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 23 South Korea atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 24 Latin America atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 25 Latin America atherectomy devices market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 27 Mexico atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 28 Argentina atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa atherectomy devices market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 33 UAE atherectomy devices market, by type, 2018 - 2030 (USD Million)
Table 34 Kuwait atherectomy devices market, by type, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Atherectomy devices: Market outlook
Fig. 9 Atherectomy devices: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Atherectomy devices market driver impact
Fig. 15 Atherectomy devices market restraint impact
Fig. 16 Atherectomy devices market strategic initiatives analysis
Fig. 17 Atherectomy devices market: Type movement analysis
Fig. 18 Atherectomy devices market: Type outlook and key takeaways
Fig. 19 Directional atherectomy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Rotational atherectomy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Orbital atherectomy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Laser market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Global atherectomy devices market: Regional movement analysis
Fig. 24 Global atherectomy devices market: Regional outlook and key takeaways
Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Germany market estimates and forecasts, 2018 - 2030
Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Global Atherectomy Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Directional Atherectomy
    • Rotational Atherectomy
    • Orbital Atherectomy
    • Laser Atherectomy
  • Global Atherectomy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America 
      • North America Atherectomy Devices Market, Type Outlook
        • Directional Atherectomy
        • Rotational Atherectomy
        • Orbital Atherectomy
        • Laser Atherectomy
      • U.S.
        • U.S. Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Canada
        • Canada Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
    • Europe
      • Europe Atherectomy Devices Market, Type Outlook
        • Directional Atherectomy
        • Rotational Atherectomy
        • Orbital Atherectomy
        • Laser Atherectomy
      • UK
        • UK Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Germany
        • Germany Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • France
        • France Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Italy
        • Italy Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Spain
        • Spain Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Sweden
        • Sweden Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Norway
        • Norway Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Denmark
        • Demark Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
    • Asia Pacific
      • Asia Pacific Atherectomy Devices Market, Type Outlook
        • Directional Atherectomy
        • Rotational Atherectomy
        • Orbital Atherectomy
        • Laser Atherectomy
      • Japan
        • Japan Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • China
        • China Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • India
        • India Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Australia
        • Australia Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Thailand
        • Thailand Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • South Korea
        • South Korea Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
    • Latin America
      • Latin America Atherectomy Devices Market, Type Outlook
        • Directional Atherectomy
        • Rotational Atherectomy
        • Orbital Atherectomy
        • Laser Atherectomy
      • Brazil
        • Brazil Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Mexico
        • Mexico Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Argentina
        • Argentina Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
    • Middle East and Africa
      • Middle East and Africa Atherectomy Devices Market, Type Outlook
        • Directional Atherectomy
        • Rotational Atherectomy
        • Orbital Atherectomy
        • Laser Atherectomy
      • South Africa
        • South Africa Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Saudi Arabia
        • Saudi Arabia Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • UAE
        • UAE Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy
      • Kuwait
        • Kuwait Atherectomy Devices Market, Type Outlook
          • Directional Atherectomy
          • Rotational Atherectomy
          • Orbital Atherectomy
          • Laser Atherectomy

Atherectomy Devices Market Dynamics

Driver: Increasing prevalence of target diseases

More than 250 million people worldwide suffer from peripheral artery disease (PAD) which also include low-income countries to some extent. The prevalence of PAD increased by 24% between 2000 to 2010 and continues to grow at an exponential rate. Both high and low-income countries have this prevalence. Low-income countries witnessed a growth of 29% while high-income countries witnessed a growth of 13% in the last decade. PAD also increases the risk of stroke and heart attack. It also leads to ischemic amputations and according to an estimation, 150,000 such cases are noted annually in the U.S. alone. Risk factors such as smoking, high blood pressure, diabetes, high cholesterol, and rising geriatric population are anticipated to increase the prevalence of PAD manifolds. This, in turn, will lead to an exponential growth for atherectomy procedures over the forecast period.

Driver: Preference to minimally invasive procedures

The demand for minimally invasive procedures/surgeries (MIS) is on a rise. These procedures result in fewer traumas to the patient and quicker recovery than invasive procedures. Research results published by manufacturers (Ethicon Endo-Surgery Inc.) suggests that minimally invasive surgeries are rapidly replacing open/invasive surgeries, owing to the following factors:

  • Higher patient satisfaction levels owing to lesser incision wounds.

  • Involve relatively lesser number of hospital stays and therefore, are economically viable.

  • Involve lesser number of post-surgery complications and lower mortality rates.

One more reason for this shift is the possibilities of infection with invasive surgeries. Atherectomy is a minimally invasive procedures and therefore, the rising demand for minimally invasive surgeries will render as a high impact driver for atherectomy market during the forecast period.

Restraint: Lack of level 1 evidence for atherectomy

Level 1 evidence is the evidence based clinical practice guidelines which are based on ten results of a randomized controlled trial. Atherectomy, though a popular technique, lacks a reliable evidence based study. The clinical trials carried out in the past were conducted by industry players active in this space. Moreover, lack of such study does not allow physicians to compare the modalities to a standard. This results in each case with level 1 evidence thus hampering the number of cases handled per physician.

What Does This Report Include?

This section will provide insights into the contents included in this atherectomy devices market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Atherectomy devices market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Atherectomy devices market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the atherectomy devices market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for atherectomy devices market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of atherectomy devices market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Atherectomy Devices Market Categorization:

The atherectomy devices market was categorized into two segments, namely type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), and regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Segment Market Methodology:

The atherectomy devices market was segmented into types and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The atherectomy devices market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Atherectomy devices market companies & financials:

The atherectomy devices market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Boston Scientific Corporation - Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in wide range of interventional medical specialties. The company was established in 1979 in the U.S. Boston Scientific Corporation offered their products in seven core businesses: Cardiac Rhythm Management (CRM), Urology and Pelvic Health, Interventional Cardiology, Endoscopy, Peripheral Interventions (PI), Electrophysiology (EP), and Neuromodulation. As of December 2015, the company had six international manufacturing facilities with three in Ireland, two in Costa Rica and one facility in Puerto Rico. Moreover, it has R&D capabilities in Ireland, China and India. In 2015, the company launched 75 new products globally.

  • Cardiovascular Systems Inc. - Cardiovascular Systems Inc. was incorporated in 2000 and is headquartered in Minnesota, U.S. The company has expertise in medical devices for conditions such as coronary and peripheral vascular diseases. The company has a patented product used in orbital atherectomy. They hold a specialty in medical devices used for PAD and CAD and capabilities including braid range of arteries such as leg arteries both above and below knee. The company also provides accessory products used in such as guide wires.

  • Medtronic plc. - Medtronic, headquartered in Ireland, was established in the year 1949. Worldwide, the company serves in more than 160 countries. In January 2015, Medtronic completed the acquisition of Covidien plc. After the transaction, Medtronic, Inc. and Covidien plc were combined and became subsidiaries of Medtronic plc. The company operates in four business segments: cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes. The cardiac and vascular group is composed of the coronary & structural heart, cardiac rhythm & heart failure, and aortic & peripheral vascular divisions.

  • Spectranetics - Spectranetics was established in 1984 and is headquartered in the U.S. The company develops and manufactures medical devices specially used in minimally invasive procedures. The company operates in three segments; Vascular intervention, Lead Management, and Laser services. The company has presence in over 65 countries with almost 60 distributors.

  • Volcano Corporation - Volcano Corporation was established in 2000 and is headquartered in U.S. The company has a highly diverse technologies portfolio making therapy and imaging minimally invasive. The company offers intravascular ultrasound (IVUS) product line indicated to measure the severity of cardiac and peripheral conditions. The company operates in more than 14 countries and has almost 1,800 employees. The company was acquired by Royal Philips in February 2015. This added Philip’s offerings in imaging and navigations systems.

  • Avinger Inc. - Avinger Inc. was incorporated in 2007 and is active in developing cardiovascular solutions focusing of PAD. The company has lumivascular platform and mainly develops products based on it. It has presence in the U.S. and some selected countries in Europe. Their lumivascular platform offers real time visualization during the endovascular procedures. The company was conducting a clinical trial named VISION which was designed its atherectomy solution, Pantheris system. The study had 55 patients enrolled and the results were released at the Leipzig Interventional Course conference.

  • Bayer AG - Bayer AG, founded in 1863, is a German pharmaceutical and chemical company. Bayer's core business includes human pharmaceuticals, veterinary pharmaceuticals, human healthcare products, biotechnology products, and agricultural chemicals. Bayer is an innovation company and employed with 60,000 people in 2014. Bayer Healthcare specializes in general and specialty medicines. The company is involved in the marketing of four different verticals, medical care, consumer care, animal health, and pharmaceuticals.

  • Straub Medical AG - Straub Medical AG is a Switzerland based company founded in 1997. The company develops and manufactures medical devices specific to vascular conditions. The devices are mainly minimally invasive. The company distributes its products in more than 50 countries across the globe. Their product lines are named Rotarex, Aspirex, Capturex, and different drive systems and guidewires.

  • ST. Jude Medical - St. Jude Medical is a medical devices company founded in 1976 and established in the U.S. The company offers medical devices in 6 treatment areas, which include heart failure, arrhythmias, vascular diseases, structural heart, chronic pain, and neurological diseases. The company offers various devices for vascular care, which include guidewires, endomyocardial biopsy forceps, hemostasis management products, peripheral vascular embolization, temporary bipolar pacing catheters, intravascular diagnostics & imaging, and vascular access.

  • BARD Peripheral Vascular - C. R. Bard is a U.S. based company engaged in the development, manufacturing, and development of life enhancing, innovative medical technologies since 1907. The company is operating in the following key segments: vascular, urology, oncology, and surgical specialties. In recent years, the company has expanded products beyond the company’s traditional market such as biosurgery, targeted temperature management, and home care urology products.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Atherectomy Devices Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Atherectomy Devices Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
Jump to content
pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Or view our licence options:

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.